Navigation Links
Healthcare Industry Leader Virginia Rybski Remembered
Date:5/13/2013

SCOTTSDALE, Ariz., May 13, 2013 /PRNewswire/ -- Regenesis Biomedical, Inc., a medical technology company focused on tissue regeneration, announced today that CEO Virginia Rybski lost her battle with pancreatic cancer.  Virginia was compassionately dedicated to her family, colleagues, patients and faith.

(Photo:  http://photos.prnewswire.com/prnh/20130513/LA13153)

(Logo:  http://photos.prnewswire.com/prnh/20120109/LA31405LOGO)

"We celebrate the privilege to have worked with such a talented leader, who was the driving force behind Regenesis' success," said John Voris , Chairman of the Board of Directors.  "Virginia's legacy includes a capable and dedicated management team that remains intact.  They are committed to achieving her vision of reaching patients in need of pain relief with the Provant® Therapy System."  

Ms. Rybski served Regenesis most recently as President, Chief Executive Officer and Board Director.  She combined 35 years experience founding and building emerging bioscience companies, by developing and commercializing numerous advanced-technology healthcare products.  Virginia earned a Bachelor of Arts in Molecular Biology from the University of North Carolina, and a Masters in Hospital Administration from the University of Phoenix.  She served on the Board of Directors for AdvaMed, the advanced medical technology association, as well as serving on the Emerging Growth Company Council, the Payment Advisory Work Group, and the Wound Sector Group.  She also served on the Board of Directors for AZBIO, the Arizona biotechnology and medical device association.

Virginia is survived by her husband Tom, and daughters Savannah and Olivia.  Her family provided the opportunity to support pancreatic research, through the Pancreatic Cancer Action Network at https://netcommunity.pancan.org/sslpage.aspx?pid=218

Regenesis will soon make an announcement regarding the CEO succession plan.

About Regenesis Biomedical

Regenesis Biomedical, Inc. is a privately held medical technology company focused on developing and marketing noninvasive regenerative medicine products.  Regenesis developed, patented, and now markets the Provant Therapy System.  Our customers include health care facilities, acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home health care agencies, and outpatient clinics.

About the Provant® Therapy System

Provant uses pulsed radio frequency energy (PRFE) to facilitate reduction of the pain and edema associated with post-operative, superficial soft tissues.

Contact: Regenesis Biomedical, Inc.
Scott Robey , Vice President Marketing
www.regenesisbio.com
480-970-4970 phone


'/>"/>
SOURCE Regenesis Biomedical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CitiusTechs BI-Clinical Platform for Healthcare BI & Analytics Receives NCQA HEDIS Certification
2. Actavis Cancels Presentation at Bank of America Merrill Lynch Healthcare Conference
3. Isis Pharmaceuticals to Present at the 2013 UBS Global Healthcare Conference
4. Lexicon To Present At The Bank of America Merrill Lynch Healthcare Conference
5. Healthcare Corporation of America Sets Date for Release of its First-Quarter Results and Conference Call
6. Bayer Employee Named Rising Star by Healthcare Businesswomens Association
7. Maxim Healthcare Services Names National Caregiver of the Year Winner
8. Allied Healthcare Products Reports Loss On Depressed Sales
9. BidMed Awarded Equipment Liquidation and Related Services Agreement with the Premier Healthcare Alliance
10. Millennium HealthCare Signs Exclusive Distribution Agreement with Heart Smart Inc.
11. Cynosure to Present at UBS Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
Breaking Medicine News(10 mins):